Omalizumab for chronic spontaneous urticaria in real-life practice

被引：0
|
作者：
Cubiro, Xavier [1 ]
Spertino, Jorge [1 ]
Puig, Lluis [1 ]
Serra-Baldrich, Esther [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6868
引用
收藏
页码：AB209 / AB209
页数：1
相关论文
共 50 条
  • [31] Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America
    Cherrez-Ojeda, Ivan
    Maurer, Marcus
    Bernstein, Jonathan A.
    Vanegas, Emanuel
    Felix, Miguel
    Ramon, German D.
    Ensina, Luis Felipe
    Larco Sousa, Jose Ignacio
    Matos Benavides, Edgar Emilio
    Cardona Villa, R.
    Staffeld, P. Latour
    Maria Morfin-Maciel, Blanca
    Mori, Jose
    Wilches C, Paul
    Mata, Valeria L.
    Cherrez, Annia
    WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (02):
  • [32] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
  • [33] Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience
    Acar, Ayda
    Gerceker Turk, Bengu
    Ertam Sagduyu, Ilgen
    Ceylan, Can
    Ozturk, Gunseli
    Unal, Idil
    CUTANEOUS AND OCULAR TOXICOLOGY, 2020, 39 (03) : 249 - 253
  • [34] Omalizumab for severe chronic spontaneous urticaria (CSU)-real life experience of 251 patients
    Vadasz, Z.
    Asher, I
    Tal, Y.
    Rotem, M.
    Shichter-Confino, V
    Greif, Y.
    Kessel, A.
    Agmon-Levin, N.
    Benor, S.
    Lachover-Roth, I
    Zeldin, Y.
    Stein, M.
    Toker, O.
    Mahlab-Guri, K.
    Bezalel-Rosenberg, S.
    Hassoun, J.
    Toubi, E.
    Sthoeger, Z.
    ALLERGY, 2017, 72 : 716 - 716
  • [35] Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real-life clinical practice in Taiwan
    Cho, Y-T.
    Pao, Y. -C.
    Chu, C. -Y.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (01) : 41 - 49
  • [36] Real-life study of patients treated with omalizumab for chronic spontaneous urticaria in France: 6-month data of the LUCIOL study
    Barbaud, A.
    Staumont-Salle, D.
    Bouillet, L.
    Vicaut, E.
    Tetart, F.
    Azib-Meftah, S.
    Milpied, B.
    Fougerousse, A.
    Karine, B.
    Pelvet, B.
    Le Guen, S.
    Berard, F.
    ALLERGY, 2019, 74 : 115 - 116
  • [37] Omalizumab in the treatment of chronic spontaneous urticaria in pediatric patients from the age of 6 years (real-life experience of one center)
    Petrovicova, O.
    Banovcin, P.
    Malicherova, E. Jurkova
    Bobcakova, A.
    Jesenak, M.
    ALLERGY, 2023, 78
  • [38] Real-world dosing of omalizumab for chronic spontaneous urticaria
    McIntyre, Amanda P.
    Viswanathan, Ravi K.
    Moss, Mark H.
    Mathur, Sameer K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (02) : 211 - 212
  • [39] Real world experience of Omalizumab for refractory chronic spontaneous urticaria
    Leeman, Lucy
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (12): : 1688 - 1688
  • [40] Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey
    Buyukozturk, Suna
    Gelincik, Asli
    Demirturk, Mustafa
    Kocaturk, Emek
    Colakoglu, Bahattin
    Dal, Murat
    JOURNAL OF DERMATOLOGY, 2012, 39 (05): : 439 - 442
12345